2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34865644 | Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study. | 2021 Dec 5 | 2 |
| 2 | 32860031 | Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. | 2020 Oct 21 | 1 |